AtriCure Valuation
| ATRC Stock | USD 36.16 0.01 0.03% |
At this time, the firm appears to be undervalued. AtriCure shows a prevailing Real Value of $44.59 per share. The current price of the firm is $36.16. Our model approximates the value of AtriCure from analyzing the firm fundamentals such as Current Valuation of 1.71 B, profit margin of (0.09) %, and Return On Equity of -0.0839 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting AtriCure's valuation include:
Price Book 3.791 | Enterprise Value 1.7 B | Enterprise Value Ebitda (135.97) | Price Sales 3.9399 | Enterprise Value Revenue 3.82 |
Undervalued
Today
Please note that AtriCure's price fluctuation is very steady at this time. Calculation of the real value of AtriCure is based on 3 months time horizon. Increasing AtriCure's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since AtriCure is currently traded on the exchange, buyers and sellers on that exchange determine the market value of AtriCure Stock. However, AtriCure's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 36.16 | Real 44.59 | Target 65.33 | Hype 37.36 | Naive 34.8 |
The real value of AtriCure Stock, also known as its intrinsic value, is the underlying worth of AtriCure Company, which is reflected in its stock price. It is based on AtriCure's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of AtriCure's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of AtriCure helps investors to forecast how AtriCure stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of AtriCure more accurately as focusing exclusively on AtriCure's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use AtriCure's intrinsic value based on its ongoing forecasts of AtriCure's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against AtriCure's closest peers. If more than one evaluation category is relevant for AtriCure we suggest using both methods to arrive at a better estimate.
AtriCure Cash |
|
AtriCure Valuation Trend
Comparing AtriCure's enterprise value against its market capitalization is a good way to estimate the value of AtriCure uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
AtriCure Total Value Analysis
AtriCure is presently projected to have valuation of 1.71 B with market capitalization of 1.76 B, debt of 74.49 M, and cash on hands of 118.45 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the AtriCure fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.71 B | 1.76 B | 74.49 M | 118.45 M |
AtriCure Investor Information
About 97.0% of the company shares are held by institutions such as insurance companies. The book value of AtriCure was presently reported as 9.54. The company recorded a loss per share of 0.83. AtriCure last dividend was issued on the 30th of September 2010. Based on the measurements of operating efficiency obtained from AtriCure's historical financial statements, AtriCure is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.AtriCure Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. AtriCure has an asset utilization ratio of 65.03 percent. This indicates that the Company is making $0.65 for each dollar of assets. An increasing asset utilization means that AtriCure is more efficient with each dollar of assets it utilizes for everyday operations.AtriCure Ownership Allocation
The majority of AtriCure outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in AtriCure to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in AtriCure. Please pay attention to any change in the institutional holdings of AtriCure as this could imply that something significant has changed or is about to change at the company. On August 15, 2024, Representative Josh Gottheimer of US Congress acquired under $15k worth of AtriCure's common stock.AtriCure Profitability Analysis
The company reported the previous year's revenue of 399.25 M. Net Loss for the year was (30.44 M) with profit before overhead, payroll, taxes, and interest of 245.94 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates AtriCure's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in AtriCure and how it compares across the competition.
About AtriCure Valuation
The stock valuation mechanism determines AtriCure's current worth on a weekly basis. Our valuation model uses a comparative analysis of AtriCure. We calculate exposure to AtriCure's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of AtriCure's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 300.4 M | 315.4 M | |
| Pretax Profit Margin | (0.07) | (0.08) | |
| Operating Profit Margin | (0.07) | (0.07) | |
| Net Loss | (0.08) | (0.08) | |
| Gross Profit Margin | 0.75 | 0.58 |
AtriCure Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 46.3 M |
AtriCure Current Valuation Indicators
Valuation refers to the process of determining the present value of AtriCure and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value AtriCure we look at many different elements of the entity such as AtriCure's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as AtriCure, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use AtriCure's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes AtriCure's worth.Complementary Tools for AtriCure Stock analysis
When running AtriCure's price analysis, check to measure AtriCure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AtriCure is operating at the current time. Most of AtriCure's value examination focuses on studying past and present price action to predict the probability of AtriCure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AtriCure's price. Additionally, you may evaluate how the addition of AtriCure to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| CEOs Directory Screen CEOs from public companies around the world | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |